Cargando…

Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia

Gene therapy for hypercholesterolemia offers the potential to sustainably ameliorate disease for life with a single dose. In this study, we demonstrate the combinatorial effects of codon and vector optimization, which significantly improve the efficacy of an adeno-associated virus (AAV) vector in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lili, Muthuramu, Ilayaraja, Somanathan, Suryanarayan, Zhang, Hong, Bell, Peter, He, Zhenning, Yu, Hongwei, Zhu, Yanqing, Tretiakova, Anna P., Wilson, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237527/ https://www.ncbi.nlm.nih.gov/pubmed/34258325 http://dx.doi.org/10.1016/j.omtm.2021.04.017

Ejemplares similares

Cholesterol lowering attenuates pressure overload-induced heart failure in mice with mild hypercholesterolemia
por: Muthuramu, Ilayaraja, et al.
Publicado: (2019)

Higher Seroprevalence of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies Among Racial Minorities in the United States
por: Khatri, Arpana, et al.
Publicado: (2022)

Rationale for using centralized transduction inhibition assays in three phase 3 rAAV gene therapy clinical trials
por: Schulz, Martin, et al.
Publicado: (2023)

HDL dysfunction, function, and heart failure
por: Mishra, Mudit, et al.
Publicado: (2019)

Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Muthuramu, Ilayaraja, et al.
Publicado: (2022)

Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors
por: Tseng, Yu-Shan, et al.
Publicado: (2014)

Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension
por: Mishra, Mudit, et al.
Publicado: (2020)

Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors
por: Wang, Lili, et al.
Publicado: (2011)

Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome
por: Greig, Jenny A., et al.
Publicado: (2018)

The Liver as a Target Organ for Gene Therapy: State of the Art, Challenges, and Future Perspectives
por: Jacobs, Frank, et al.
Publicado: (2012)

Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2019)

A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
por: Yang, Yang, et al.
Publicado: (2016)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Selective Homocysteine Lowering Gene Transfer Improves Infarct Healing, Attenuates Remodelling, and Enhances Diastolic Function after Myocardial Infarction in Mice
por: Muthuramu, Ilayaraja, et al.
Publicado: (2013)

The Impact of Lipoproteins on Wound Healing: Topical HDL Therapy Corrects Delayed Wound Healing in Apolipoprotein E Deficient Mice
por: Gordts, Stephanie C., et al.
Publicado: (2014)

Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice
por: Mishra, Mudit, et al.
Publicado: (2018)

Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2019)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Generation of a familial hypercholesterolemia model in non-human primate
por: Sato, Akira, et al.
Publicado: (2023)

Three-Dimensional Visualization of Transcription Sites and Their Association with Splicing Factor–Rich Nuclear Speckles
por: Wei, Xiangyun, et al.
Publicado: (1999)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis
por: Kassim, Sadik H., et al.
Publicado: (2010)

Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011)

AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)

AAV gene therapy vectors in the TMJ
por: Brouxhon, Sabine M., et al.
Publicado: (2022)

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
por: Skorput, Alexander G. J., et al.
Publicado: (2022)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload
por: Amin, Ruhul, et al.
Publicado: (2017)

Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors
por: Horiuchi, Makoto, et al.
Publicado: (2022)

Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors
por: Horiuchi, Makoto, et al.
Publicado: (2022)

Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors
por: Ling, Chen, et al.
Publicado: (2016)

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia
por: Bell, Damon A, et al.
Publicado: (2012)

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
por: Zeltner, Nadja, et al.
Publicado: (2010)

Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
por: Orlowski, Alejandro, et al.
Publicado: (2020)

Lipid Lowering and HDL Raising Gene Transfer Increase Endothelial Progenitor Cells, Enhance Myocardial Vascularity, and Improve Diastolic Function
por: Gordts, Stephanie C., et al.
Publicado: (2012)

Intramuscular Injection of AAV8 in Mice and Macaques Is Associated with Substantial Hepatic Targeting and Transgene Expression
por: Greig, Jenny A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_prhc7pcsf7bnvicfmi2t9mssfi